Add Trial
Sign In

Checkmate 9LA – CA209-9LA - Hosted By


A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Study Type Treatment
Sponsor Name BMS
Disease type Non-Small Cell Lung Cancer
Disease Stage IV
Clinical Status First line
Phase III
Intervention / Treatment Nivolumab + Ipilimumab + Chemotherapy vs Chemotherapy Alone
Research Site McGill University Health Center
Investigator Dr Scott Owen
Coordinator Olivier Bouchereau
Telephone number
Fax number
Study start date July 20, 2017
Study end date
Trial Status Recruiting
Study Type Treatment
Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage IV
Clinical Status Advanced Disease 1st Line
Phase Phase I
Intervention / Treatment
Research Site Montreal, QC, McGill University Health Center
Telephone Number +1 (514) 934-4411
Fax Number
Study Start Date
Study End Date
Trial Status


Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

Claim listing: Checkmate 9LA – CA209-9LA

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message


Account details will be confirmed via email.

Reset Your Password